These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 32640024

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mortality associated with third-generation cephalosporin resistance in Enterobacterales bloodstream infections at eight sub-Saharan African hospitals (MBIRA): a prospective cohort study.
    Aiken AM, Rehman AM, de Kraker MEA, Madrid L, Kebede M, Labi AK, Obeng-Nkrumah N, Nyamwaya B, Kagucia E, Cocker D, Kawaza K, Lester R, Iregbu KC, Medugu N, Nwajiobi-Princewill PI, Dramowski A, Sonda T, Hemed A, Fwoloshi S, Ojok D, Scott JAG, Whitelaw A, MBIRA study collaborators.
    Lancet Infect Dis; 2023 Nov; 23(11):1280-1290. PubMed ID: 37454672
    [Abstract] [Full Text] [Related]

  • 3. Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections.
    Lodise TP, Bonine NG, Ye JM, Folse HJ, Gillard P.
    BMC Infect Dis; 2019 Aug 14; 19(1):718. PubMed ID: 31412809
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis.
    Rottier WC, Bamberg YR, Dorigo-Zetsma JW, van der Linden PD, Ammerlaan HS, Bonten MJ.
    Clin Infect Dis; 2015 Jun 01; 60(11):1622-30. PubMed ID: 25694654
    [Abstract] [Full Text] [Related]

  • 5. Guidance of empirical antimicrobial therapy by surveillance cultures in high-risk neutropenic patients: a retrospective cohort study.
    de la Court JR, Heijmans J, Huynh J, Sieswerda E, de Jonge NA, van Dijk K, Sigaloff KCE, Schade RP.
    Antimicrob Resist Infect Control; 2022 Dec 18; 11(1):160. PubMed ID: 36529742
    [Abstract] [Full Text] [Related]

  • 6. Mortality associated with third-generation cephalosporin resistance in Enterobacteriaceae bloodstream infections at one South African hospital.
    Dramowski A, Aiken AM, Rehman AM, Snyman Y, Reuter S, Grundmann H, Scott JAG, de Kraker MEA, Whitelaw A.
    J Glob Antimicrob Resist; 2022 Jun 18; 29():176-184. PubMed ID: 35283332
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-centre retrospective propensity-weighted study.
    Maillard A, Delory T, Bernier J, Villa A, Chaibi K, Escaut L, Contejean A, Bercot B, Robert J, El Alaoui F, Tankovic J, Poupet H, Cuzon G, Lafaurie M, Surgers L, Joseph A, Paccoud O, Molina JM, Bleibtreu A, Treatment of AmpC-producing Enterobacterales Study Group.
    Int J Antimicrob Agents; 2023 Jul 18; 62(1):106809. PubMed ID: 37028731
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Appropriateness of empirical antibiotic prescription for bloodstream infections in an emergency department from 2006 to 2018: impact of the spread of ESBL-producing Enterobacterales.
    Clemenceau M, Ahmed-Elie S, Vilfaillot A, Chocron R, Compain F, Lebeaux D, Grohs P.
    Eur J Clin Microbiol Infect Dis; 2022 Jan 18; 41(1):71-77. PubMed ID: 34553311
    [Abstract] [Full Text] [Related]

  • 10. Attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections: a prospective cohort study in Suva, Fiji.
    Loftus MJ, Young-Sharma TEMW, Lee SJ, Wati S, Badoordeen GZ, Blakeway LV, Byers SMH, Cheng AC, Cooper BS, Cottingham H, Jenney AWJ, Hawkey J, Macesic N, Naidu R, Prasad A, Prasad V, Tudravu L, Vakatawa T, van Gorp E, Wisniewski JA, Rafai E, Peleg AY, Stewardson AJ.
    J Glob Antimicrob Resist; 2022 Sep 18; 30():286-293. PubMed ID: 35738385
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: a systematic review.
    Lester R, Musicha P, van Ginneken N, Dramowski A, Hamer DH, Garner P, Feasey NA.
    J Antimicrob Chemother; 2020 Mar 01; 75(3):492-507. PubMed ID: 31742611
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features.
    Courpon-Claudinon A, Lefort A, Panhard X, Clermont O, Dornic Q, Fantin B, Mentré F, Wolff M, Denamur E, Branger C, COLIBAFI Group.
    Clin Microbiol Infect; 2011 Apr 01; 17(4):557-65. PubMed ID: 20649802
    [Abstract] [Full Text] [Related]

  • 16. Individual and population level costs and health-related quality of life outcomes of third-generation cephalosporin resistant bloodstream infection in Blantyre, Malawi.
    Lester R, Mango J, Mallewa J, Jewell CP, Lalloo DA, Feasey NA, Maheswaran H.
    PLOS Glob Public Health; 2023 Apr 01; 3(6):e0001589. PubMed ID: 37347746
    [Abstract] [Full Text] [Related]

  • 17. Mortality attributable to third-generation cephalosporin resistance in Gram-negative bloodstream infections in African hospitals: a multi-site retrospective study.
    Dramowski A, Ong'ayo G, Rehman AM, Whitelaw A, Labi AK, Obeng-Nkrumah N, Ndir A, Magwenzi MT, Onyedibe K, Wolkewitz M, de Kraker MEA, Scott JAG, Aiken AM, MBIRA study collaborators .
    JAC Antimicrob Resist; 2021 Mar 01; 3(1):dlaa130. PubMed ID: 34223079
    [Abstract] [Full Text] [Related]

  • 18. Third-generation cephalosporin resistant gram-negative bacteraemia in patients with haematological malignancy; an 11-year multi-centre retrospective study.
    de la Court JR, Woudt SHS, Schoffelen AF, Heijmans J, de Jonge NA, van der Bruggen T, Bomers MK, Lambregts MMC, Schade RP, Sigaloff KCE, ISIS-AR study group.
    Ann Clin Microbiol Antimicrob; 2022 Nov 28; 21(1):54. PubMed ID: 36443758
    [Abstract] [Full Text] [Related]

  • 19. Incidence of and Risk Factors for Third-Generation Cephalosporin-Resistant Escherichia coli Bloodstream Infections in Children.
    Cheng J, Liu Y, Li S, Pu K, Yang L, Tan L.
    Infect Drug Resist; 2024 Nov 28; 17():543-550. PubMed ID: 38352624
    [Abstract] [Full Text] [Related]

  • 20. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
    Etienne M, Van Elslande H, Choplin-Renard J, Pestel-Caron M, Caron F.
    Med Mal Infect; 2014 May 28; 44(5):217-22. PubMed ID: 24787633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.